BIO INX SRL
4.0 FTEThe score of BIO INX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets +207 % Headcount (avg FTE) +122 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BIO INX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
BIO INX's financial analysis
- Solvency-22.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BIO INX
BIO INX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0784.459.685
- VAT number
- BE0784459685
- Peppol
- Registered · 0208:0784459685 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Apr 2022
- Registered office
- 9052 Ghent
- Size
- Micro · 4.0 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
BIO INX (SRL) has been based in Ghent since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 322,253 € and equity of −272,921 €; its revenue is not published. With 4.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -22.1%, below the median of its sector (60.4%).
Companies similar to BIO INX
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Hougardy Nicolas SRL Research and experimental development on natural sciences and engineering Habay · balance sheet €1.20m
- Dr. Nike Van Doninck - Endocrinologie Research and experimental development on natural sciences and engineering Lochristi · balance sheet €1.19m
- Quidditas Research and experimental development on natural sciences and engineering Liège · balance sheet €1.19m
- Eilc Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €1.32m
- Dokter Bernard Kint Research and experimental development on natural sciences and engineering Antwerp · balance sheet €1.07m
- Piette Yves Research and experimental development on natural sciences and engineering Jabbeke · balance sheet €1.05m
- AB PSY Dinant Research and experimental development on natural sciences and engineering Dinant · balance sheet €1.03m
Frequently asked questions about BIO INX
What is the revenue of BIO INX?
BIO INX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BIO INX?
In Belgium, the VAT number is the company number prefixed with BE: BE0784459685 for BIO INX, if the company is VAT-registered. Its company number (CBE) is 0784.459.685.
Where is the registered office of BIO INX?
According to the CBE register, the registered office of BIO INX is in 9052 Ghent.
What is the equity of BIO INX?
At the close of the 2025 financial year, the equity of BIO INX amounts to -272,921 €, a solvency of -22.1% of total assets.
How many people work at BIO INX?
4.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BIO INX?
The register lists 4 active mandates at BIO INX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BIO INX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →